Skip to main content Accessibility help
Hostname: page-component-544b6db54f-lmg95 Total loading time: 0.312 Render date: 2021-10-20T08:29:55.649Z Has data issue: true Feature Flags: { "shouldUseShareProductTool": true, "shouldUseHypothesis": true, "isUnsiloEnabled": true, "metricsAbstractViews": false, "figures": true, "newCiteModal": false, "newCitedByModal": true, "newEcommerce": true, "newUsageEvents": true }

4 - Surgical Management of Patients with Epithelial Ovarian Cancer

Published online by Cambridge University Press:  11 September 2009

Janos Balega
Gynaecological Cancer Centre, St Bartholomew's Hospital, London, UK.
John H. Shepherd
Gynaecological Cancer Centre, St Bartholomew's Hospital, London, UK.
Rodney Reznek
St. Bartholomew's Hospital, London
Get access


Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Cancer of the Ovary , pp. 69 - 81
Publisher: Cambridge University Press
Print publication year: 2006

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)


Jemal, A., Tiwari, R. C., Murray, T., et al. American Cancer Society. Cancer statistics, 2004. CA Cancer J Clin (2004), 54:8–29.CrossRefGoogle ScholarPubMed
Benedet, J. L., Hacker, N. F. and Ngan, H. Y. S., eds. Staging Classifications and Clinical Practice Guidelines of Gynaecological Cancers, 2nd Edition. FIGO Committee on Gynecologic Oncology and IGCS Guidelines Committee, 2003. Reprinted from Int J Gynecol Obstet (2000), 70:207–312.Google Scholar
Young, R. C., Decker, D. G., Wharton, J. T., et al. Staging laparotomy in early ovarian cancer. JAMA (1983), 250:3072–6.CrossRefGoogle ScholarPubMed
Soper, J. T., Johnson, P., Johnson, V., et al. Comprehensive restaging laparotomy in women with apparent early ovarian carcinoma. Obstet Gynecol (1992), 80:949–53.Google ScholarPubMed
Eisenkop, S. M. and Spirtos, N. M.. The clinical significance of occult macroscopically positive retroperitoneal nodes in patients with epithelial ovarian cancer. Gynecol Oncol (2001), 82:143–9.CrossRefGoogle ScholarPubMed
Morice, P., Joulie, F., Camatte, S., et al. Lymph node involvement in epithelial ovarian cancer: analysis of 276 pelvic and paraaortic lymphadenectomies and surgical implications. Am Coll Surg (2003), 197:198–205.CrossRefGoogle ScholarPubMed
Trimbos, J. B., Vergote, I., Bolis, G., et al. Impact of adjuvant chemotherapy and surgical staging in early-stage ovarian carcinoma: European Organisation for Research and Treatment of Cancer-Adjuvant ChemoTherapy in Ovarian Neoplasm trial. J Natl Cancer Inst (2003), 95:113–25.CrossRefGoogle ScholarPubMed
Griffiths, C. T.. Surgical resection of tumor bulk in the primary treatment of ovarian carcinoma. Natl Cancer Inst Monogr (1975), 42:101–4.Google ScholarPubMed
Prefontaine, M., Gelfand, A. T., Donovan, J. T. and Powell, J. L.. Reproducibility of tumor measurements in ovarian cancer: a study of interobserver variability. Gynecol Oncol (1994), 55:87–90.CrossRefGoogle ScholarPubMed
Hoskins, W. J., McGuire, W. P., Brady, M. F., et al. The effect of diameter of largest residual disease on survival after primary cytoreductive surgery in patients with suboptimal residual epithelial ovarian carcinoma. Am J Obstet Gynecol (1994), 170:974–9.CrossRefGoogle ScholarPubMed
Hunter, R. W., Alexander, N. D. and Soutter, W. P.. Meta-analysis of surgery in advanced ovarian carcinoma: is maximum cytoreductive surgery an independent determinant of prognosis?Am J Obstet Gynecol (1992), 166:504–11.CrossRefGoogle ScholarPubMed
Bristow, R. E., Tomacruz, R. S., Armstrong, D. K., et al. Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: a meta-analysis. J Clin Oncol (2002), 20:1248–59.CrossRefGoogle ScholarPubMed
Eisenkop, S. M., Friedman, R. L. and Wang, H. J.. Complete cytoreductive surgery is feasible and maximizes survival in patients with advanced epithelial ovarian cancer: a prospective study. Gynecol Oncol (1998), 69:103–8.CrossRefGoogle ScholarPubMed
Allen, D. G. and Coulter, J.. Survival of patients with epithelial ovarian cancer and the effect of lymphadenectomy in those with stage 3 disease. Aust NZ J Obstet Gynaecol (1999), 39:420–4.Google ScholarPubMed
Kikkawa, F., Ishikawa, H., Tamakoshi, K., et al. Prognostic evaluation of lymphadenectomy for epithelial ovarian cancer. J Surg Oncol (1995), 60:227–31.CrossRefGoogle ScholarPubMed
Yokoyama, Y., Sakamoto, T., Sato, S., et al. Evaluation of cytoreductive surgery with pelvic and paraaortic lymphadenectomy and intermittent cisplatin-based combination chemotherapy for improvement of long-term survival in ovarian cancer. Eur J Gynaecol Oncol (1999), 20:361–6.Google ScholarPubMed
Benedetti-Panici, B., Maggioni, A., Hacker, N., et al. Systematic aortic and pelvic lymphadenectomy versus resection of bulky nodes only in optimally debulked advanced ovarian cancer: a randomized clinical trial. J Natl Cancer Inst (2005), 97:560–6.CrossRefGoogle Scholar
Kehoe, S., Powell, J., Wilson, S., et al. The influence of the operating surgeon's specialisation on patient survival in ovarian carcinoma. Br J Cancer (1994), 70:1014–17.CrossRefGoogle ScholarPubMed
Nguyen, H. N., Averette, H. E., Hoskins, W., et al. National survey of ovarian carcinoma. Part V. The impact of physician's specialty on patients' survival. Cancer (1993), 72:3663–70.3.0.CO;2-S>CrossRefGoogle ScholarPubMed
Giede, K. C., Kieser, K., Dodge, J., et al. Who should operate on patients with ovarian cancer? An evidence-based review. Gynecol Oncol (2005), 99:447–61.CrossRefGoogle ScholarPubMed
Junor, E. J., Hole, D. J., McNulty, L., et al. Specialist gynaecologists and survival outcome in ovarian cancer: a Scottish national study of 1,866 patients. Br J Obstet Gynaecol (1999), 106:1130–6.CrossRefGoogle Scholar
Junor, E. J., Hole, D. J. and Gillis, C. R.. Management of ovarian cancer: referral to a multidisciplinary team matters. Br J Cancer (1994), 70:363–70.CrossRefGoogle ScholarPubMed
Covens, A. L.. A critique of surgical cytoreduction in advanced ovarian cancer. Gynecol Oncol (2000), 78:269–74.CrossRefGoogle ScholarPubMed
Hacker, N. F., Berek, J. S., Lagasse, L. D., et al. Primary cytoreductive surgery for epithelial ovarian cancer. Obstet Gynecol (1983), 61:413–20.Google ScholarPubMed
Hoskins, W. J., Bundy, B. N., Thigpen, J. T., et al. The influence of cytoreductive surgery on recurrence-free interval and survival in small-volume stage III epithelial ovarian cancer: a Gynecologic Oncology Group study. Gynecol Oncol (1992), 47:159–66.CrossRefGoogle ScholarPubMed
Crawford, S. C., Vasey, P. A., Paul, J., et al. Does aggressive surgery only benefit patients with less advanced ovarian cancer? Results from an international comparison within the SCOTROC-1 Trial. J Clin Oncol (2005), 23:8802–11.CrossRefGoogle ScholarPubMed
Vasey, P. A., Jayson, G. C., Gordon, A., et al. Scottish Gynaecological Cancer Trials Group. Phase III randomized trial of docetaxel-carboplatin versus paclitaxel-carboplatin as first-line chemotherapy for ovarian carcinoma. J Natl Cancer Inst (2004), 96:1682–91.CrossRefGoogle ScholarPubMed
Brockbank, E. C., Ind, T. E., Barton, D. P., et al. Preoperative predictors of suboptimal primary surgical cytoreduction in women with clinical evidence of advanced primary epithelial ovarian cancer. Int J Gynecol Cancer (2004), 14:42–50.CrossRefGoogle ScholarPubMed
Jacob, J. H., Gershenson, D. M., Morris, M., et al. Neoadjuvant chemotherapy and interval debulking for advanced epithelial ovarian cancer. Gynecol Oncol (1991), 42:146–50.CrossRefGoogle ScholarPubMed
Onnis, A., Marchetti, M., Padovan, P., et al. Neoadjuvant chemotherapy in advanced ovarian cancer. Eur J Gynaecol Oncol (1996), 17:393–6.Google ScholarPubMed
Schwartz, P. E., Rutherford, T. J., Chambers, J. T., et al. Neoadjuvant chemotherapy for advanced ovarian cancer: long-term survival. Gynecol Oncol (1999), 72:93–9.CrossRefGoogle ScholarPubMed
Ushijima, K., Ota, S., Komai, K., et al. Clinical assessment of neoadjuvant chemotherapy and interval cytoreductive surgery for unresectable advanced ovarian cancer. Int Surg (2002), 87:185–90.Google ScholarPubMed
Vrscaj, M. U. and Rakar, S.. Neoadjuvant chemotherapy for advanced epithelial ovarian carcinoma: a retrospective case-control study. Eur J Gynaecol Oncol (2002), 23:405–10.Google ScholarPubMed
Kuhn, W., Rutke, S., Spathe, K., et al. Neoadjuvant chemotherapy followed by tumor debulking prolongs survival for patients with poor prognosis in International Federation of Gynecology and Obstetrics Stage IIIC ovarian carcinoma. Cancer (2001), 92:2585–91.3.0.CO;2-#>CrossRefGoogle ScholarPubMed
Vergote, I. B., Wever, I., Decloedt, J., et al. Neoadjuvant chemotherapy versus primary debulking surgery in advanced ovarian cancer. Semin Oncol (2000), 27 (Suppl 7):31–6.Google ScholarPubMed
Vergote, I., Wever, I., Tjalma, W., et al. Neoadjuvant chemotherapy or primary debulking surgery in advanced ovarian carcinoma: a retrospective analysis of 285 patients. Gynecol Oncol (1998), 71:431–6.CrossRefGoogle ScholarPubMed
Volz, J., Koster, S., Spacek, Z., et al. The influence of pneumoperitoneum used in laparoscopic surgery on an intraabdominal tumor growth. Cancer (1999), 86:770–4.3.0.CO;2-3>CrossRefGoogle ScholarPubMed
Abu-Rustum, N. R., Sonoda, Y., Chi, D. S., et al. The effects of CO2 pneumoperitoneum on the survival of women with persistent metastatic ovarian cancer. Gynecol Oncol (2003), 90:431–4.CrossRefGoogle ScholarPubMed
Abu-Rustum, N. R., Rhee, E. H., Chi, D. S., et al. Subcutaneous tumor implantation after laparoscopic procedures in women with malignant disease. Obstet Gynecol (2004), 103:480–7.CrossRefGoogle ScholarPubMed
Nagarsheth, N. P., Rahaman, J., Cohen, C. J., et al. The incidence of port-site metastases in gynecologic cancers. JSLS (2004), 8:133–9.Google ScholarPubMed
Cavina, E., Goletti, O., Molea, N., et al. Trocar site tumor recurrences. May pneumoperitoneum be responsible?Surg Endosc (1998), 12:1294–6.CrossRefGoogle ScholarPubMed
Dowdy, S. C., Mullany, S. A., Brandt, K. R., et al. The utility of computed tomography scans in predicting suboptimal cytoreductive surgery in women with advanced ovarian carcinoma. Cancer (2004), 101:346–52.CrossRefGoogle ScholarPubMed
Everett, E. N., Heuser, C. C., Pastore, L. M., et al. Predictors of suboptimal surgical cytoreduction in women treated with initial cytoreductive surgery for advanced stage epithelial ovarian cancer. Am J Obstet Gynecol (2005), 193:568–74.CrossRefGoogle ScholarPubMed
Qayyum, A., Coakley, F. V., Westphalen, A. C., et al. Role of CT and MR imaging in predicting optimal cytoreduction of newly diagnosed primary epithelial ovarian cancer. Gynecol Oncol (2005), 96:301–6.CrossRefGoogle Scholar
Bristow, R. E., Duska, L. R., Lambrou, N. C., et al. A model for predicting surgical outcome in patients with advanced ovarian carcinoma using computed tomography. Cancer (2000), 89:1532–40.3.0.CO;2-A>CrossRefGoogle ScholarPubMed
Nelson, B. E., Rosenfield, A. T. and Schwartz, P. E.. Preoperative abdominopelvic computed tomographic prediction of optimal cytoreduction in epithelial ovarian carcinoma. J Clin Oncol (1993), 11:166–72.CrossRefGoogle ScholarPubMed
Forstner, R., Hricak, H., Occhipinti, K. A., et al. Ovarian cancer: staging with CT and MR imaging. Radiology (1995), 197:619–26.CrossRefGoogle ScholarPubMed
Burg, M. E., Lent, M., Buyse, M., et al. The effect of debulking surgery after induction chemotherapy on the prognosis in advanced epithelial ovarian cancer. Gynecological Cancer Cooperative Group of the European Organization for Research and Treatment of Cancer. N Engl J Med (1995), 332:629–34.CrossRefGoogle ScholarPubMed
Rose, P. G., Nerenstone, S., Brady, M. F., et al. Gynecologic Oncology Group. Secondary surgical cytoreduction for advanced ovarian carcinoma. N Engl J Med (2004), 351:2489–97.CrossRefGoogle ScholarPubMed
Harter, P. and Bois, A. du. The role of surgery in ovarian cancer with special emphasis on cytoreductive surgery for recurrence. Curr Opin Oncol (2005), 17:505–14.CrossRefGoogle ScholarPubMed
Eisenkop, S. M., Friedman, R. L. and Spirtos, N. M.. The role of secondary cytoreductive surgery in the treatment of patients with recurrent epithelial ovarian carcinoma. Cancer (2000), 88:144–53.3.0.CO;2-X>CrossRefGoogle ScholarPubMed
Dvoretsky, P. M., Richards, K. A., Angel, C., et al. Survival time, causes of death, and tumor/treatment-related morbidity in 100 women with ovarian cancer. Hum Pathol (1988), 19:1273–9.CrossRefGoogle ScholarPubMed
Tunca, J. C., Buchler, D. A., Mack, E. A., et al. The management of ovarian-cancer-caused bowel obstruction. Gynecol Oncol (1981), 12:186–92.CrossRefGoogle ScholarPubMed
Pothuri, B., Vaidya, A., Aghajanian, C., et al. Palliative surgery for bowel obstruction in recurrent ovarian cancer: an updated series. Gynecol Oncol (2003), 89:306–13.CrossRefGoogle Scholar
Feuer, D. J., Broadley, K. E., Shepherd, J. H., et al. Systematic review of surgery in malignant bowel obstruction in advanced gynecological and gastrointestinal cancer. The Systematic Review Steering Committee. Gynecol Oncol (1999), 75:313–22.CrossRefGoogle ScholarPubMed
Krebs, H. B. and Goplerud, D. R.. Surgical management of bowel obstruction in advanced ovarian carcinoma. Obstet Gynecol (1983), 61:327–30.Google ScholarPubMed
Vera-Garcia, C.. A patient's perspective on ovarian cancer as a chronic disease – devaluing a survivor's challenge. Gynecol Oncol (2005), 96:19–20.CrossRefGoogle ScholarPubMed

Send book to Kindle

To send this book to your Kindle, first ensure is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about sending to your Kindle.

Note you can select to send to either the or variations. ‘’ emails are free but can only be sent to your device when it is connected to wi-fi. ‘’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats

Send book to Dropbox

To send content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about sending content to Dropbox.

Available formats

Send book to Google Drive

To send content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about sending content to Google Drive.

Available formats